Europe Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast to 2022

June 2017 | | ID: E4948D598DDEN
Renub Research

Abstracts

Europe Breast Cancer Screening Market will be less than US$ 8 Billion by the end of year 2022. Breast cancer is one of the most dangerous diseases in the Europe region. Its incidence rate in Europe was 92.9 women per 100,000 women and mortality rate was 23.1 per 100,000 women. So, most of the countries of Europe has adopted or in the process to adopt breast cancer screening in their national cancer screening programs. Mammography screening is most commonly used as breast cancer screening method in Europe.

Germany has the Highest Market Share in Breast Cancer Screening Market, but it will lose its Market Leader Position to United Kingdom in Future

Germany is the clear winner in the breast cancer screening market as it has huge women population, advanced healthcare infrastructure and government supported screening programs. Under the programs, all women age between 50-69 years are eligible for free breast cancer screening test in every two years. Under this program eligible woman gets a letter from the regional mammography program center to participate in the breast cancer screening program.

Germany will maintain their Dominating Position in Europe Breast Cancer Ultrasound Screening Market

Due to strong healthcare expending power and increasing breast cancer awareness among the women, Germany is forecast to hold its dominating place in Europe Breast Cancer Screening Market. Presently, Germany, Italy and Spain are steadily losing their market share on comparison to this all other countries such as United Kingdom, France, Switzerland, Norway and Netherlands ultrasound screening market share is expected to grow in the forecasting period 2017-2022.

Europe Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast to 2022 is the 2nd Report published by Renub Research on Breast Cancer Screening Market. The report analyzes the Europe Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market. This report studies separate comprehensive analytics for the 8 countries: United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway and Switzerland

This 122 page report with 120 Figures and 2 Tables provides a complete analysis of top 8 courtiers of Europe Breast Cancer Screening Market. All the 8 countries in the report have been studied from 7 viewpoints.

• Countries Breast Cancer Mammography Screening Population Scenario and Forecast
• Countries Breast Cancer MRI & Ultrasound Screening Population Scenario and Forecast
• Countries Breast Cancer Mammography Screening Market and Forecast
• Countries Breast Cancer MRI Screening Market and Forecast
• Countries Breast Cancer Ultrasound Screening Market and Forecast
• Countries Breast Cancer Screening Market and Forecast
• Worldwide Breast Cancer Screening Market and Forecast

All the 8 Countries Studied in the Report are as Follows

1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Netherlands
7. Norway
8. Switzerland

Contents

1 EXECUTIVE SUMMARY

2 EUROPE SCREENING POPULATION ANALYSIS

2.1 Europe Breast Cancer Mammography Screening Population & Forecast
2.2 Europe Breast Cancer MRI & Ultrasound Screening Population & Forecast

3 EUROPE BREAST CANCER SCREENING MARKET ANALYSIS

3.1 Europe Breast Cancer Screening Market & Forecast
  3.1.1 Europe Breast Cancer Mammography Screening Market & Forecast
  3.1.2 Europe Breast Cancer MRI Screening Market & Forecast
  3.1.3 Europe Breast Cancer Ultrasound Screening Market & Forecast

4 EUROPE BREAST CANCER SCREENING POPULATION & MARKET SHARE ANALYSIS

4.1 Europe Breast Cancer Mammography Screening Population Share & Forecast
4.2 Europe Breast Cancer MRI & Ultrasound Screening Population Share & Forecast

5 EUROPE BREAST CANCER SCREENING MARKET SHARE ANALYSIS

5.1 Worldwide Breast Cancer Screening Market Share & Forecast
5.2 Europe Breast Cancer Mammography Screening Market Share & Forecast
5.3 Europe Breast Cancer MRI Screening Market Share & Forecast
5.4 Europe Breast Cancer Ultrasound Screening Market Share & Forecast

6 UNITED KINGDOM

6.1 United Kingdom Breast Cancer Mammography Screening Population & Forecast
6.2 United Kingdom Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast
6.3 United Kingdom Breast Cancer Screening Market & Forecast
  6.3.1 United Kingdom Breast Cancer Mammography Screening Market & Forecast
  6.3.2 United Kingdom Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
  6.3.3 United Kingdom Breast Cancer Ultrasound Screening Market & Forecast

7 FRANCE

7.1 France Breast Cancer Mammography Screening Population & Forecast
7.2 France Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast
7.3 France Breast Cancer Screening Market & Forecast
  7.3.1 France Breast Cancer Mammography Screening Market & Forecast
  7.3.2 France Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
  7.3.3 France Breast Cancer Ultrasound Screening Market & Forecast

8 GERMANY

8.1 Germany Breast Cancer Mammography Screening Population & Forecast
8.2 Germany Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast
8.3 Germany Breast Cancer Screening Market & Forecast
  8.3.1 Germany Breast Cancer Mammography Screening Market & Forecast
  8.3.2 Germany Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
  8.3.3 Germany Breast Cancer Ultrasound Screening Market & Forecast

9 ITALY

9.1 Italy Breast Cancer Mammography Screening Population & Forecast
9.2 Italy Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast
9.3 Italy Breast Cancer Screening Market & Forecast
  9.3.1 Italy Breast Cancer Mammography Screening Market & Forecast
  9.3.2 Italy Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
  9.3.3 Italy Breast Cancer Ultrasound Screening Market & Forecast

10 SPAIN

10.1 Spain Breast Cancer Mammography Screening Population & Forecast
10.2 Spain Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast
10.3 Spain Breast Cancer Screening Market & Forecast
  10.3.1 Spain Breast Cancer Mammography Screening Market & Forecast
  10.3.2 Spain Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
  10.3.3 Spain Breast Cancer Ultrasound Screening Market & Forecast

11 SWITZERLAND

11.1 Switzerland Breast Cancer Mammography Screening Population & Forecast
11.2 Switzerland Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast
11.3 Switzerland Breast Cancer Screening Market & Forecast
  11.3.1 Switzerland Breast Cancer Mammography Screening Market & Forecast
  11.3.2 Switzerland Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
  11.3.3 Switzerland Breast Cancer Ultrasound Screening Market & Forecast

12 NORWAY

12.1 Norway Breast Cancer Mammography Screening Population & Forecast
12.2 Norway Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast
12.3 Norway Breast Cancer Screening Market & Forecast
  12.3.1 Norway Breast Cancer Mammography Screening Market & Forecast
  12.3.2 Norway Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
  12.3.3 Norway Breast Cancer Ultrasound Screening Market & Forecast

13 NETHERLANDS

13.1 Netherlands Breast Cancer Mammography Screening Population & Forecast
13.2 Netherlands Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast
13.3 Netherlands Breast Cancer Screening Market & Forecast
  13.3.1 Netherlands Breast Cancer Mammography Screening Market & Forecast
  13.3.2 Netherlands Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
  13.3.3 Netherlands Breast Cancer Ultrasound Screening Market & Forecast

14 EUROPE BREAST CANCER SCREENING MARKET - GROWTH DRIVERS

14.1 Increasing Breast Cancer Care Awareness Initiatives
14.2 Increasing Breast Cancer Cases

15 BREAST CANCER SCREENING MARKET CHALLENGES

15.1 Difference of Opinion on Breast Cancer Mammography Screening

List Of Figures

LIST OF FIGURES:

Figure 2‑1: Europe – Breast Cancer Mammography Screening Population (Million), 2010 – 2016
Figure 2‑2: Europe – Forecast for Breast Cancer Mammography Screening Population (Million), 2017 – 2022
Figure 2‑3: Europe – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
Figure 2‑4: Europe – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
Figure 3‑1: Europe – Breast Cancer Screening Market (Billion US$), 2010 – 2016
Figure 3‑2: Europe – Forecast for Breast Cancer Screening Market (Billion US$), 2017 – 2022
Figure 3‑3: Europe – Breast Cancer Mammography Screening Market (Billion US$), 2010 – 2016
Figure 3‑4: Europe – Forecast for Breast Cancer Mammography Screening Market (Billion US$), 2017 – 2022
Figure 3‑5: Europe – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
Figure 3‑6: Europe – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
Figure 3‑7: Europe – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
Figure 3‑8: Europe – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022
Figure 4‑1: Europe – Breast Cancer Mammography Screening Population Share (Percent), 2010 – 2016
Figure 4‑2: Europe – Forecast for Breast Cancer Mammography Screening Population Share (Percent), 2017 – 2022
Figure 4‑3: Europe – Breast Cancer MRI & Ultrasound Screening Population Share (Percent), 2010 – 2016
Figure 4‑4: Europe – Forecast for Breast Cancer MRI & Ultrasound Screening Population Share (Percent), 2017 – 2022
Figure 5‑1: Europe – Breast Cancer Screening Market Share (Percent), 2010 – 2016
Figure 5‑2: Europe – Forecast for Breast Cancer Screening Market Share (Percent), 2017 – 2022
Figure 5‑3: Europe – Breast Cancer Mammography Screening Market Share (Percent), 2010 – 2016
Figure 5‑4: Europe – Forecast for Breast Cancer Mammography Screening Market Share (Percent), 2017 – 2022
Figure 5‑5: Europe – Breast Cancer MRI Screening Market Share (Percent), 2010 – 2016
Figure 5‑6: Europe – Forecast for Breast Cancer MRI Screening Market Share (Percent), 2017 – 2022
Figure 5‑7: Europe – Breast Cancer Ultrasound Screening Market Share (Percent), 2010 – 2016
Figure 5‑8: Europe – Forecast for Breast Cancer Ultrasound Screening Market Share (Percent), 2017 – 2022
Figure 6‑1: United Kingdom – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
Figure 6‑2: United Kingdom – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
Figure 6‑3: United Kingdom – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
Figure 6‑4: United Kingdom – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
Figure 6‑5: United Kingdom – Breast Cancer Screening Market (Million US$), 2010 – 2016
Figure 6‑6: United Kingdom – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
Figure 6‑7: United Kingdom – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
Figure 6‑8: United Kingdom – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
Figure 6‑9: United Kingdom – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
Figure 6‑10: United Kingdom – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
Figure 6‑11: United Kingdom – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
Figure 6‑12: United Kingdom – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022
Figure 7‑1: France – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
Figure 7‑2: France – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
Figure 7‑3: France – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
Figure 7‑4: France – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
Figure 7‑5: France – Breast Cancer Screening Market (Million US$), 2010 – 2016
Figure 7‑6: France – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
Figure 7‑7: France – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
Figure 7‑8: France – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
Figure 7‑9: France – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
Figure 7‑10: France – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
Figure 7‑11: France – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
Figure 7‑12: France – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022
Figure 8‑1: Germany – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
Figure 8‑2: Germany – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
Figure 8‑3: Germany – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
Figure 8‑4: Germany – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
Figure 8‑5: Germany – Breast Cancer Screening Market (Million US$), 2010 – 2016
Figure 8‑6: Germany – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
Figure 8‑7: Germany – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
Figure 8‑8: Germany – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
Figure 8‑9: Germany – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
Figure 8‑10: Germany – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
Figure 8‑11: Germany – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
Figure 8‑12: Germany – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022
Figure 9‑1: Italy – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
Figure 9‑2: Italy – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
Figure 9‑3: Italy – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
Figure 9‑4: Italy – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
Figure 9‑5: Italy – Breast Cancer Screening Market (Million US$), 2010 – 2016
Figure 9‑6: Italy – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
Figure 9‑7: Italy – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
Figure 9‑8: Italy – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
Figure 9‑9: Italy – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
Figure 9‑10: Italy – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
Figure 9‑11: Italy – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
Figure 9‑12: Italy – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022
Figure 10‑1: Spain – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
Figure 10‑2: Spain – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
Figure 10‑3: Spain – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
Figure 10‑4: Spain – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
Figure 10‑5: Spain – Breast Cancer Screening Market (Million US$), 2010 – 2016
Figure 10‑6: Spain – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
Figure 10‑7: Spain – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
Figure 10‑8: Spain – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
Figure 10‑9: Spain – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
Figure 10‑10: Spain – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
Figure 10‑11: Spain – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
Figure 10‑12: Spain – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022
Figure 11‑1: Switzerland – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
Figure 11‑2: Switzerland – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
Figure 11‑3: Switzerland – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
Figure 11‑4: Switzerland – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
Figure 11‑5: Switzerland – Breast Cancer Screening Market (Million US$), 2010 – 2016
Figure 11‑6: Switzerland – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
Figure 11‑7: Switzerland – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
Figure 11‑8: Switzerland – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
Figure 11‑9: Switzerland – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
Figure 11‑10: Switzerland – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
Figure 11‑11: Switzerland – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
Figure 11‑12: Switzerland – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022
Figure 12‑1: Norway – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
Figure 12‑2: Norway – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
Figure 12‑3: Norway – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
Figure 12‑4: Norway – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
Figure 12‑5: Norway – Breast Cancer Screening Market (Million US$), 2010 – 2016
Figure 12‑6: Norway – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
Figure 12‑7: Norway – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
Figure 12‑8: Norway – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
Figure 12‑9: Norway – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
Figure 12‑10: Norway – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
Figure 12‑11: Norway – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
Figure 12‑12: Norway – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022
Figure 13‑1: Netherlands – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
Figure 13‑2: Netherlands – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
Figure 13‑3: Netherlands – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
Figure 13‑4: Netherlands – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
Figure 13‑5: Netherlands – Breast Cancer Screening Market (Million US$), 2010 – 2016
Figure 13‑6: Netherlands – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
Figure 13‑7: Netherlands – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
Figure 13‑8: Netherlands – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
Figure 13‑9: Netherlands – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
Figure 13‑10: Netherlands – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
Figure 13‑11: Netherlands – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
Figure 13‑12: Netherlands – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

List Of Tables

LIST OF TABLES:

Table 26–1: Worldwide – Breast cancer Incidence Rate (Number), 2008 & 2012
Table 26–2: Worldwide – Breast cancer Mortality Rate (Number), 2012